**Appendices and nomenclature**


**31**

**Author details**

Maria Vincent1

New York, USA

3 BlephEx LLC, Kentucky, USA

provided the original work is properly cited.

, Jose Quintero2

1 Donald and Barbara Zucker School of Medicine at Hofstra/Northwell,

© 2020 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by/3.0), which permits unrestricted use, distribution, and reproduction in any medium,

2 Ophthalmic Consultants of Long Island, New York, USA

\*Address all correspondence to: hankcornea@gmail.com

, Henry D. Perry1,2\* and James M. Rynerson3

*Biofilm Theory for Lid Margin and Dry Eye Disease DOI: http://dx.doi.org/10.5772/intechopen.89969*

*Biofilm Theory for Lid Margin and Dry Eye Disease DOI: http://dx.doi.org/10.5772/intechopen.89969*

*Ocular Surface Diseases - Some Current Date on Tear Film Problem and Keratoconic Diagnosis*

We would like to thank Dr. Donna B. Stolz, Dr. Michael B. Choi, Dr. Michael Hadjiargyrou and Nicole Radova, B.S. for their contributions to this chapter.

James M Rynerson is the President and CEO of BlephEx, LLC and Henry D Perry is the senior founding partner of Ophthalmic Consultants of Long Island. The

Biofilm Groups of microbial cells enclosed in a

Cylindrical dandruff Sleeve of material that forms around the

DEBS Dry Eye Blepharitis Syndrome; a pro-

Goblet cells Specialized epithelial cells that secrete

Microblepharoexfoliation (MBE) Lid margin cleaning, with electric rotary

Virulence factors Factors released by bacteria that cause

Blepharitis Inflammation of the eyelid

surface

biofilm

against pathogens

lated biofilm

toxins Volcano sign Swollen, follicular tissue around the base

of the lash

matrix of primarily polysaccharide material that are intimately associated with a

eyelash, likely due to biofilm accumulation combined with eyelash growth

posed unifying diagnosis that links both dry eye and blepharitis as stages of inflammation caused by progression of

mucus, helping maintain the barrier

sponge, in an effort to remove accumu-

inflammation, including exotoxins, enzymes, super-antigens and cytolytic

authors report no other conflicts of interest in this work.

**Acknowledgements**

**Conflict of interest**

**Appendices and nomenclature**

**30**
